Researcher sitting in a confidential booth carrying out an online consultation with a trial participant.

Find a research project

Find a research project

Browse our clinical research projects. Find a project you'd like to join. Filter the list by condition / recruiting status.

Octopus Clinical Trial

A multi-arm, multi-stage clinical drug trial for people with progressive MS.

 

MND-SMART

An innovative clinical drugs trial testing potential new treatments that may slow, stop or reverse the progression of MND.

Lighthouse II clinical trial

Phase 3 clinical trial to determine if Triumeq improves survival in amyotrophic lateral sclerosis (ALS) compared with placebo.

FutureMS Phase 2

The FutureMS-2 project - recruiting previous participants to continue their participation.

International MS Microbiome Study

Research study looking at the role of gut bacteria in people living with multiple sclerosis.

The StarMS Trial

A clinical trial aiming to compare the efficacy and safety of Autologous Haematopoietic Stem Cell Transplantation versus 'highly effective' Disease Modifying Treatments.

The Jeffrey Young Research Programme - A research initiative to investigate Progressive Supranuclear Palsy

A three year laboratory based research programme bringing together internationally leading expertise in human stem cells, drug discovery and pathology.

ESTEEM MS Study

Dimethyl Fumarate Observational Study

NeuroCARE

Our platform for people in Scotland with a neurological condition, and their carers, to sign up to help research and find out about opportunities to take part in studies and trials.

MS-STAT2

A clinical drug trial, testing whether a statin could be used to treat secondary progressive multiple sclerosis.

ChariotMS Clinical Trial

ChariotMS will test whether a drug called cladribine can slow down the worsening of hand and arm function for people with advanced multiple sclerosis.

Holistic Assessment of Non-Motor Symptoms for People with Motor Neuron Disease (NMS-MND)

A questionnaire study to investigate how people with MND are affected by 'non-motor symptoms' - those not related to movement.

PITMS study

Predicting Individual Treatment responses towards personalised medicine in MS. A study to develop a computer tool that predicts responses to MS medication.

DELIVER-MS

DELIVER-MS is a study that will show whether starting treatment with a highly effective disease-modifying therapy (DMT) improves the prognosis for people with MS.

Regenerative Neurology Tissue Bank

We are building up a comprehensive bank of donated biological samples from people with neurological conditions, to help our research.

ROPAD Study

A global observational study focusing on the role of genetics in Parkinson's.

Brain banking

Some people with neurodegenerative conditions choose to donate brain and spinal cord tissue for research after they die.

Dundee and Edinburgh Parkinson's Research Initiative

The Universities of Dundee and Edinburgh have joined forces to help deliver new treatments for people with Parkinson's and accelerate access to clinical trials.

PROHIBIT-ICH

Investigating if intensive blood pressure treatment, guided by bluetooth technology, can reduce brain injury amongst people who've had an intracerebral haemorrhage (stroke).

ENRICH-AF

A randomised clinical trial investigating if people with atrial fibrillation (irregular heartbeat), who have had a brain haemorrhage actually benefit from starting anticoagulant drugs.

 

TRIDENT

TRIDENT is testing whether using a triple pill to control blood pressure (BP) is best for people who have had a stroke due to a brain haemorrhage and who have mildly or moderately raised BP.

FutureMS Phase 1

FutureMS used clinical examinations, brain imaging and genetics to try to predict how severe an individual's MS will be. The study is now fully recruited.

Vitamin D levels in people with MS

This study aims to improve our understanding of the levels of Vitamin D, and factors affecting this, in people with MS across the UK.

Edinburgh Long Covid Study

Part of a UK wide collaboration with clinicians and academics from around the United Kingdom.

×